Irene Volitakis

11.7k total citations · 4 hit papers
87 papers, 8.8k citations indexed

About

Irene Volitakis is a scholar working on Nutrition and Dietetics, Physiology and Molecular Biology. According to data from OpenAlex, Irene Volitakis has authored 87 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Nutrition and Dietetics, 53 papers in Physiology and 20 papers in Molecular Biology. Recurrent topics in Irene Volitakis's work include Trace Elements in Health (54 papers), Alzheimer's disease research and treatments (49 papers) and Heavy Metal Exposure and Toxicity (16 papers). Irene Volitakis is often cited by papers focused on Trace Elements in Health (54 papers), Alzheimer's disease research and treatments (49 papers) and Heavy Metal Exposure and Toxicity (16 papers). Irene Volitakis collaborates with scholars based in Australia, United States and Germany. Irene Volitakis's co-authors include Ashley I. Bush, Robert A. Cherny, Colin L. Masters, Kevin J. Barnham, Konrad Beyreuther, Qiao‐Xin Li, Anthony R. White, Paul A. Adlard, Roberto Cappai and Catriona McLean and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Irene Volitakis

87 papers receiving 8.7k citations

Hit Papers

Treatment with a Copper-Zinc Chelator Markedly and Rapidl... 2001 2026 2009 2017 2001 2003 2001 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
    2001 1.2k citations Robert A. Cherny, Catriona McLean et al. profile →
  2. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease
    2003 810 citations Craig Ritchie, Ashley I. Bush et al. Archives of Neurology profile →
  3. Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits
    2001 557 citations Irene Volitakis, Robert A. Cherny et al. Journal of Biological Chemistry profile →
  4. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
    2012 472 citations Peng Lei, Scott Ayton et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Volitakis Australia 44 4.8k 3.6k 2.6k 1.4k 1.1k 87 8.8k
Robert A. Cherny Australia 56 8.3k 1.7× 4.5k 1.2× 4.3k 1.7× 1.6k 1.1× 2.0k 1.8× 96 13.5k
Mark A. Lovell United States 56 6.2k 1.3× 2.3k 0.6× 5.5k 2.2× 890 0.6× 1.5k 1.4× 109 12.4k
Peter Faller France 59 5.6k 1.2× 3.4k 0.9× 4.1k 1.6× 976 0.7× 1.4k 1.3× 181 11.2k
Qiao‐Xin Li Australia 48 4.7k 1.0× 1.5k 0.4× 2.5k 1.0× 620 0.4× 888 0.8× 144 8.0k
Jack T. Rogers United States 52 3.9k 0.8× 1.8k 0.5× 3.1k 1.2× 528 0.4× 1.1k 1.0× 122 9.1k
Roberto Cappai Australia 69 9.1k 1.9× 3.6k 1.0× 6.9k 2.7× 1.1k 0.8× 1.9k 1.7× 235 15.9k
Lawrence M. Sayre United States 51 4.5k 1.0× 1.6k 0.4× 4.9k 1.9× 535 0.4× 1.2k 1.1× 183 12.3k
Scott Ayton Australia 47 2.6k 0.5× 1.6k 0.4× 3.0k 1.2× 406 0.3× 506 0.5× 129 8.5k
Christelle Hureau France 47 4.6k 1.0× 2.1k 0.6× 2.6k 1.0× 374 0.3× 1.2k 1.1× 155 8.4k
Math P. Cuajungco United States 32 2.2k 0.5× 1.8k 0.5× 1.7k 0.7× 723 0.5× 523 0.5× 56 5.3k

Countries citing papers authored by Irene Volitakis

Since Specialization
Citations

This map shows the geographic impact of Irene Volitakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Volitakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Volitakis more than expected).

Fields of papers citing papers by Irene Volitakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Volitakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Volitakis. The network helps show where Irene Volitakis may publish in the future.

Co-authorship network of co-authors of Irene Volitakis

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Volitakis. A scholar is included among the top collaborators of Irene Volitakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Volitakis. Irene Volitakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Ya Hui, Abdel Ali Belaidi, Irene Volitakis, et al.. (2024). Impaired cellular copper regulation in the presence of ApoE4. Journal of Neurochemistry. 168(9). 3284–3307. 1 indexed citations
2.
Masaldan, Shashank, S Clatworthy, Irene Volitakis, et al.. (2020). Copper Ionophores as Novel Antiobesity Therapeutics. Molecules. 25(21). 4957–4957. 11 indexed citations
3.
Berggren, Kiersten L., Jianfang Chen, Julia A. Fox, et al.. (2015). Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease. Redox Biology. 4. 363–374. 31 indexed citations
4.
Lu, Zhen, Eileen Marks, Jianfang Chen, et al.. (2014). Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model. Neurobiology of Disease. 71. 34–42. 44 indexed citations
5.
Dang, Theresa N., Nastasia K.-H. Lim, Alexandra Grubman, et al.. (2014). Increased metal content in the TDP-43A315T transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Frontiers in Aging Neuroscience. 6. 15–15. 42 indexed citations
6.
Chen, Jianfang, Eileen Marks, Barry Lai, et al.. (2013). Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine. PLoS ONE. 8(10). e77023–e77023. 144 indexed citations
7.
Rembach, Alan, James D. Doecke, Blaine R. Roberts, et al.. (2013). Longitudinal Analysis of Serum Copper and Ceruloplasmin in Alzheimer's Disease. Journal of Alzheimer s Disease. 34(1). 171–182. 43 indexed citations
8.
Lei, Peng, Scott Ayton, David I. Finkelstein, et al.. (2012). Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nature Medicine. 18(2). 291–295. 472 indexed citations breakdown →
9.
Crouch, Peter J., Lin W. Hung, Paul S. Donnelly, et al.. (2011). The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity. Journal of Neurochemistry. 119(1). 220–230. 158 indexed citations
10.
James, Simon, Irene Volitakis, Paul A. Adlard, et al.. (2011). Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radical Biology and Medicine. 52(2). 298–302. 147 indexed citations
11.
Lee, Joo‐Yong, Eunsil Cho, Tae Youn Kim, et al.. (2010). Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain. BioMetals. 23(6). 1085–1095. 18 indexed citations
12.
Brazier, Marcus W., Irene Volitakis, Anthony R. White, et al.. (2010). Manganese chelation therapy extends survival in a mouse model of M1000 prion disease. Journal of Neurochemistry. 114(2). 440–451. 27 indexed citations
13.
Donnelly, Paul S., Aphrodite Caragounis, Tai Du, et al.. (2007). Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide. Journal of Biological Chemistry. 283(8). 4568–4577. 175 indexed citations
14.
White, Anthony R., Tai Du, Katrina Laughton, et al.. (2006). Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity. Journal of Biological Chemistry. 281(26). 17670–17680. 256 indexed citations
15.
Maynard, Christa J., Roberto Cappai, Irene Volitakis, et al.. (2006). Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology. Journal of Inorganic Biochemistry. 100(5-6). 952–962. 86 indexed citations
16.
Religa, Dorota, Robert A. Cherny, Irene Volitakis, et al.. (2006). Elevated cortical zinc in Alzheimer disease. Neurology. 67(1). 69–75. 223 indexed citations
17.
Siddiq, Ambreena, Issam A. Ayoub, Juan C. Chávez, et al.. (2005). Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition. Journal of Biological Chemistry. 280(50). 41732–41743. 259 indexed citations
18.
Friedlich, Avi L., Joo‐Yong Lee, Thomas van Groen, et al.. (2004). Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease. Journal of Neuroscience. 24(13). 3453–3459. 107 indexed citations
19.
Kiaei, Mahmoud, Ashley I. Bush, Brett M. Morrison, et al.. (2004). Genetically Decreased Spinal Cord Copper Concentration Prolongs Life in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Journal of Neuroscience. 24(36). 7945–7950. 42 indexed citations
20.
Ritchie, Craig, Ashley I. Bush, Andrew Mackinnon, et al.. (2003). Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease. Archives of Neurology. 60(12). 1685–1685. 810 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Cherny Breakdown of academic impact, for papers by Mark A. Lovell Breakdown of academic impact, for papers by Peter Faller Breakdown of academic impact, for papers by Qiao‐Xin Li Breakdown of academic impact, for papers by Jack T. Rogers Breakdown of academic impact, for papers by Roberto Cappai Breakdown of academic impact, for papers by Lawrence M. Sayre Breakdown of academic impact, for papers by Scott Ayton Breakdown of academic impact, for papers by Christelle Hureau Breakdown of academic impact, for papers by Math P. Cuajungco
Rankless by CCL
2026